|
|
Article: Migraine drug approved. (Imitrex)
- Article from:
- FDA Consumer
- Article date:
- March 1, 1993
CopyrightCOPYRIGHT 1993 U.S. Government Printing Office. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
People who suffer the acute pain of migraine headaches may find relief with a new injectable drug FDA approved Dec. 28. 1992, called Imitrex (sumatriptan).
In two clinical trials in the United States involving more than 1,000 patients with acute migraine headaches, a 6-milligram injection of Imitrex relieved the pain in 75 percent of the patients within one hour. A few felt pain relief within 10 to 30 minutes, and 80 percent of the patients felt pain relief after two hours.
Although effective in alleviating pain in a high proportion of patients, Imitrex is not a cure for migraines. In addition, people with underlying heart disease should not take the ...